IMMY : Summary for Imprimis Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

Imprimis Pharmaceuticals, Inc. (IMMY)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.37-0.01 (-0.42%)
At close: 4:00 PM EST
People also watch:
OCRXGLYCIPWRICCCEVOK
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.38
Open2.43
Bid2.14 x 100
Ask4.00 x 500
Day's Range2.36 - 2.46
52 Week Range2.22 - 7.36
Volume48,848
Avg. Volume58,944
Market Cap31.41M
Beta-0.45
PE Ratio (TTM)-1.54
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga7 days ago

    Imprimis CEO Talks Phenomenal Quarter: 'Shocking' Statistics, Simplification And A Trifecta For Success

    Imprimis Pharmaceuticals Inc (NASDAQ: IMMY ) is a San Diego-based small-cap pharmaceutical company that specializes in the ophthalmology space. The company is coming off an impressive 81 percent year-over-year ...

  • Capital Cube10 days ago

    ETFs with exposure to Imprimis Pharmaceuticals, Inc. : November 28, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Imprimis Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IMMY-US. Comparing the performance and risk of Imprimis Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Imprimis Pharmaceuticals, Inc. :IMMY-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016
    Capital Cube15 days ago

    Imprimis Pharmaceuticals, Inc. :IMMY-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016

    Categories: Yahoo Finance Get free summary analysis Imprimis Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Imprimis Pharmaceuticals, Inc. – Akorn, Inc., Antares Pharma, Inc., Retractable Technologies, Inc., Delcath Systems, Inc., ICU Medical, Inc., Unilife Corporation and Tandem Diabetes Care, Inc. (AKRX-US, ATRS-US, RVP-US, ... Read more (Read more...)